Liver-specific therapies for metastases of neuroendocrine pancreatic tumors

Item

http://www.wikidata.org/entity/Q37821300

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Liver-specific therapies for metastases of neuroendocrine pancreatic tumors

@en

Liver-specific therapies for metastases of neuroendocrine pancreatic tumors.

@nl

type

Item

label

Liver-specific therapies for metastases of neuroendocrine pancreatic tumors

@en

Liver-specific therapies for metastases of neuroendocrine pancreatic tumors.

@nl

prefLabel

Liver-specific therapies for metastases of neuroendocrine pancreatic tumors

@en

Liver-specific therapies for metastases of neuroendocrine pancreatic tumors.

@nl

P1476

Liver-specific therapies for metastases of neuroendocrine pancreatic tumors

@en

P2093

Detlef Klaus Bartsch

http://www.w3.org/2001/XMLSchema#string

Nils Habbe

http://www.w3.org/2001/XMLSchema#string

Patrick Michl

http://www.w3.org/2001/XMLSchema#string

Volker Fendrich

http://www.w3.org/2001/XMLSchema#string

P2860

Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors

Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors.

Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy.

Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.

Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.

Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors.

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

Endocrine tumours of the pancreas.

P304

367-373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4254/WJH.V2.I10.367

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49685978

http://www.w3.org/2001/XMLSchema#string

P698

21160945

http://www.w3.org/2001/XMLSchema#string

P932

2998945

http://www.w3.org/2001/XMLSchema#string